These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35693748)

  • 1. Erratum: Estrogen receptor α/prolactin receptor bilateral crosstalk promotes bromocriptine resistance in prolactinomas: Erratum.
    Xiao Z; Yang X; Zhang K; Liu Z; Shao Z; Song C; Wang X; Li Z
    Int J Med Sci; 2022; 19(5):831-832. PubMed ID: 35693748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor α/prolactin receptor bilateral crosstalk promotes bromocriptine resistance in prolactinomas.
    Xiao Z; Yang X; Zhang K; Liu Z; Shao Z; Song C; Wang X; Li Z
    Int J Med Sci; 2020; 17(18):3174-3189. PubMed ID: 33173437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructural localization of prolactin in estrogen-induced prolactinoma of the rat pituitary. Experimental models for the human prolactinomas and the effects of bromocriptine.
    Osamura RY; Watanabe K
    Acta Pathol Jpn; 1986 Aug; 36(8):1131-7. PubMed ID: 3776530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of MAPK11/12/13/14 (p38 MAPK) protein in dopamine agonist-resistant prolactinomas.
    Wang S; Wang A; Zhang Y; Zhu K; Wang X; Chen Y; Wu J
    BMC Endocr Disord; 2021 Nov; 21(1):235. PubMed ID: 34814904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antitumor effect of bromocriptine on estrogen-induced rat prolactinomas: special reference to changes in secretory granules by stereological analysis].
    Saitoh Y; Koizumi K; Arita N; Hayakawa T; Aono T; Matsumoto K; Mogami H; Mori H
    No To Shinkei; 1987 Apr; 39(4):347-54. PubMed ID: 3593602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of G alpha subunits mRNA levels in bromocriptine resistant prolactinomas.
    Caccavelli L; Morange-Ramos I; Kordon C; Jaquet P; Enjalbert A
    J Neuroendocrinol; 1996 Oct; 8(10):737-46. PubMed ID: 8910802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathological changes of prolactinomas treated with bromocriptine].
    Teramoto A; Takakura K; Fukushima T; Osamura Y
    No Shinkei Geka; 1982 Jun; 10(6):619-27. PubMed ID: 7121729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive prolactin response to bromocriptine in 2 patients with cabergoline-resistant prolactinomas.
    Iyer P; Molitch ME
    Endocr Pract; 2011; 17(3):e55-8. PubMed ID: 21324816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The long-term effects of pregnancy and bromocriptine treatment on prolactinomas--the value of radiologic studies.
    Badawy SZ; Marziale JC; Rosenbaum AE; Chang JK; Joy SE
    Early Pregnancy; 1997 Dec; 3(4):306-11. PubMed ID: 10086082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactinomas in infertile women: clinical and endocrine characteristics before and after 24 months of treatment with bromocriptine.
    Hajder M; Hajder E; Dervisefendic M; Samardzic R; Alic E
    Med Arch; 2013; 67(3):181-4. PubMed ID: 23848038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the new dopaminergic agonist CV 205-502 on plasma prolactin levels and tumour size in bromocriptine-resistant prolactinomas.
    Duranteau L; Chanson P; Lavoinne A; Horlait S; Lubetzki J; Kuhn JM
    Clin Endocrinol (Oxf); 1991 Jan; 34(1):25-9. PubMed ID: 1672268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erratum: Overexpression of lncRNA H19/miR-675 promotes tumorigenesis in head and neck squamous cell carcinoma: Erratum.
    Guan GF; Zhang DJ; Wen LJ; Xin D; Liu Y; Yu DJ; Su K; Zhu L; Guo YY; Wang K
    Int J Med Sci; 2022; 19(5):829-830. PubMed ID: 35693735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erratum: PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis: Erratum.
    Du P; Luo K; Li G; Zhu J; Xiao Q; Li Y; Zhang X
    Int J Med Sci; 2022; 19(3):486-487. PubMed ID: 35370468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical, electron microscopic and morphometric studies of estrogen-induced rat prolactinomas after bromocriptine treatment.
    Niwa J; Minase T; Hashi K; Mori M
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1987; 53(2):89-96. PubMed ID: 2887062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erratum: Co-culture with Endothelial Progenitor Cells promotes the Osteogenesis of Bone Mesenchymal Stem Cells via the VEGF-YAP axis in high-glucose environments: Erratum.
    Wu P; Zhang X; Hu Y; Liu D; Song J; Xu W; Tan H; Lu R; Zheng L
    Int J Med Sci; 2022; 19(6):1047-1048. PubMed ID: 35813290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrastructural localization of prolactin in the human pituitary prolactinomas and its changes by bromocriptine treatment.
    Osamura RY; Teramoto A; Watanabe K
    Acta Pathol Jpn; 1986 Aug; 36(8):1123-30. PubMed ID: 3776529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and drug therapy of prolactinoma.
    Ciccarelli E; Camanni F
    Drugs; 1996 Jun; 51(6):954-65. PubMed ID: 8736617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persisting suppression of prolactin secretion after long-term treatment with bromocriptine in patients with prolactinomas.
    Eversmann T; Fahlbusch R; Rjosk HK; von Werder K
    Acta Endocrinol (Copenh); 1979 Nov; 92(3):413-27. PubMed ID: 574700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of the two D2 dopamine receptor isoforms in bromocriptine-resistant prolactinomas.
    Caccavelli L; Feron F; Morange I; Rouer E; Benarous R; Dewailly D; Jaquet P; Kordon C; Enjalbert A
    Neuroendocrinology; 1994 Sep; 60(3):314-22. PubMed ID: 7969790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additional antitumoral effects of bromocriptine and radiotherapy in patients with prolactinomas or acromegaly.
    Coculescu M; Alessandrescu D; Stoica T; Simionescu N; Dimitriu V; Oprescu M; Chelmu S; Urba-Navicius V; Isbăşoiu O
    Endocrinologie; 1980; 18(4):277-88. PubMed ID: 7209360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.